A Calculated Execution: Florida Surgeon Sentenced to Death in Lawyer’s Murder on November 21, 2026 Posted by
Beyond the Drama: Understanding the Silent Crisis of Sepsis in Older Adults on November 21, 2026 Posted by
Beyond the Risk Calculator: Can Heart Scans Redefine Preventive Cardiology? on November 21, 2026 Posted by
From Bedside to Boardroom: How Dr. Pallav Halani’s Respiratory Roots Built a Pediatric Pulmonology Career on November 21, 2026 Posted by
Navigating the Regulatory Storm: How Proposed CMS Rules Threaten Medicaid Access for Recovery Communities on November 21, 2026 Posted by
A Sticky Solution: Could Engineered Chewing Gum Revolutionize Oral Cancer Defense? on November 21, 2026 Posted by
NewYork-Presbyterian and Spear Forge Landmark Partnership to Revolutionize Outpatient Rehabilitation Access Across NYC and Westchester on November 21, 2026 Posted by
A Calculated Execution: Florida Surgeon Sentenced to Death in Lawyer’s Murder on November 21, 2026 Posted by
Beyond the Drama: Understanding the Silent Crisis of Sepsis in Older Adults on November 21, 2026 Posted by
Beyond the Risk Calculator: Can Heart Scans Redefine Preventive Cardiology? on November 21, 2026 Posted by
From Bedside to Boardroom: How Dr. Pallav Halani’s Respiratory Roots Built a Pediatric Pulmonology Career on November 21, 2026 Posted by
Posted in Medical Innovations Alnylam Fights Back: Biotech Defends RNAi Therapeutics Following AstraZeneca Trial Setback on August 30, 2026
Posted in Digital Health Tools The ATTR-CM Standoff: AstraZeneca’s Clinical Failure Shakes the Foundations of a Multibillion-Dollar Market on August 28, 2026
Posted in Digital Health Tools AstraZeneca and Amgen’s Tezspire Poised to Challenge Market Leaders in Eosinophilic Esophagitis Treatment on August 27, 2026
Posted in Medical Innovations Tezspire’s Clinical Success in Eosinophilic Esophagitis Marks a Potential New Era for AstraZeneca and Amgen on August 27, 2026
Posted in Medical Innovations AstraZeneca’s Strategic Ambition Stalls: Volrustomig Trial Terminated Following Efficacy Concerns on August 18, 2026
Posted in Medical Innovations The $400 Billion Question: Why Wall Street is Panicking Over a Potential AstraZeneca-Bristol Myers Megamerger on August 3, 2026
Posted in Respiratory Health AstraZeneca’s Breztri Aerosphere: A New Era for Asthma Maintenance Therapy in the U.S. on July 23, 2026
Posted in Digital Health Tools AstraZeneca Challenges Merck in COPD Arena with $200 Million Sino Biopharm Deal on July 13, 2026
Posted in Digital Health Tools Setback for Ionis and AstraZeneca: Eplontersen Fails Pivotal ATTR-CM Trial on July 12, 2026
Posted in Medical Innovations AstraZeneca’s Path to Blockbuster Status Hits FDA Roadblock: A Deep Dive into the Camizestrant Delay on May 28, 2026 rifanmuazin